IDEXX Laboratories, Inc. (0J8P)
LSE
552.09
-5.03 (-0.90%)
Closed
Aug 25, 2026
Day's Range
545.00562.25
52 wk Range
504.08771.52
Financial Statements - 0J8P - IDEXX Laboratories, Inc.
Revenue
63.92M▼ 14.0%
Net Income
867.67K▲ 358.2%Net Margin 1.4%
EBITDA
2.30M▲ 143.7%
Free Cash Flow
3.20M▼ 18.8%
Income Statement
| Period Ending | 2021-10-31 | 2020-10-31 | 2019-10-31 |
|---|---|---|---|
| Sales | 63.92M | 74.33M | 86.46M |
| Cost of Goods | 47.90M | 61.25M | 70.70M |
| Gross Profit | 16.02M | 13.07M | 15.75M |
 Operating Expense | - | - | - |
| Operating Income | 1.44M | -825.31K | 540.52K |
| Non-Operating Interest | - | - | - |
| Other Income Expense | -159.16K | 629.38K | -3.76K |
| Pre Tax Income | 1.20M | -377.75K | 293.21K |
| Income Tax | 340.18K | -41.71K | 29.20K |
| Net Income | 867.67K | -336.04K | 264K |
| EPS Basic | 0.22 | -0.02 | -0.02 |
| EPS Diluted | 0.22 | -0.02 | -0.02 |
| Basic Shares Outstanding | 5.70M | 5.57M | 5.56M |
| Diluted Shares Outstanding | 5.70M | 5.57M | 5.56M |
| Ebit | - | - | - |
| Ebitda | 2.30M | 946.71K | 1.29M |
| Net Income Continuous Operations | 867.67K | -336.04K | 264K |
| Minority Interests | 387.67K | 241.74K | -358.60K |
| Preferred Stock Dividends | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
